(Q45408268)

14 December 2017

Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients (English)

1 reference

14 December 2017

0 references

1 reference

1 reference

Lin CC

1

1 reference

14 December 2017

Chen CL

2

1 reference

14 December 2017

Concejero A

3

1 reference

14 December 2017

Wang CC

4

1 reference

14 December 2017

Wang SH

5

1 reference

14 December 2017

Liu YW

6

1 reference

14 December 2017

Yang CH

7

1 reference

14 December 2017

Yong CC

8

1 reference

14 December 2017

Lin TS

9

1 reference

14 December 2017

Jawan B

10

1 reference

14 December 2017

Cheng YF

11

1 reference

14 December 2017

Eng HL

12

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

American Journal of Transplantation

14 December 2017

1 reference

14 December 2017

7

1 reference

14 December 2017

1

1 reference

14 December 2017

195-200

1 reference

Liver transplantation and de novo hepatitis B infection

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Safe use of livers from donors with positive hepatitis B core antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Hepatitis B core antibody-positive grafts: recipient's risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Immunisations in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Hepatitis B vaccination in liver transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

Infections by hepatitis B surface antigen gene mutants in Europe and North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01618.X

10.1111/J.1600-6143.2006.01618.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference